期刊文献+

伊立替康对食管癌细胞放射增敏作用及核因子κB活性的影响研究 被引量:2

Influence of irinotecan on radiation sensitization and the activity of nuclear factor κB of esophageal cancer cells
下载PDF
导出
摘要 目的 探讨伊立替康(CPT-11)对食管癌EC109细胞的放射增敏作用及核因子(NF)κB活性的影响。方法 采用MTT法观察不同浓度CPT-11(20、50、100、200μmol/L)作用24、48及72 h后的细胞存活率以筛选低细胞毒性药物浓度进行后续实验;根据实验设计分为对照组、单纯照射组和CPT-11+照射组,采用克隆形成实验检测经不同剂量X线(0、2、4、6、8和10Gy)的存活分数(SF)并通过单击多靶模型拟合细胞存活曲线计算增敏比(SER),采用流式细胞技术检测各组处理48 h后的凋亡率和caspase-3活化率,Foci焦点形成实验检测各组的DNA损伤情况,Western blotting检测各组NF-κB p65和IκB-α的蛋白水平,实时定量PCR(q PCR)检测各组的Rad51水平。结果 在20~200μmol/L范围内,随CPT-11浓度增加,EC109细胞的增殖抑制率升高,抑制效应呈浓度和时间依赖方式,差异有统计学意义(P〈0.05)。选取与CPT-11 20%抑制浓度(IC20)接近的浓度(25μmol/L)进行增敏实验。CPT-11+照射组的SF低于单纯照射组,且CPT-11+照射组的D0为1.39±0.14,单纯照射组的D0为2.46±0.17,SER为1.77。与对照组和单纯照射组比较,CPT-11+照射组的凋亡率、caspase-3活化率及Foci焦点数目均升高,而Rad51水平降低,差异有统计学意义(P〈0.05)。CPT-11+照射组的NF-κB p65水平低于其余两组,且IκB-α水平高于其余两组(P〈0.05)。结论 CPT-11可抑制食管癌EC109细胞增殖并具有放射增敏作用,同时诱导凋亡,可能与抑制NF-κB途径有关。 Objective To investigate the effect of irinotecan (CPT-11 ) on radiosensitization and nuclear factor (NF)-κB of esophageal cancer cells EC109. Methods MTT assay was used to observe the cell survival rates after treatment with different concen- trations of CPT-11 (20, 50, 100, 200 μmol/L) for 24, 48 and 72 h as to screen the concentration with low cytotoxicity drug for subse- quent experiments. According to the experimental design, the EC109 cells were divided into the control group, the irradiation group and the CPT-11+irradiation group. The survival fraction (SF) of different doses of X-rays (0, 2, 4, 6, 8 and 10 Gy) was detected by clone formation assay and the cell survival curve was calculated by using the multiple target model to calculate the enhancement ratio (SER). The activation rate of caspase-3 and apoptotic rate were detected by flow cytometry after 48 h. Foci focus formation was applied to detect the DNA damage of each group. Western blotting was used to detect the protein level of NF-κB p65 and IκB-ct in each group. The real-time quantitative polymerase chain reaction(qPCR) was applied to detect the Rad51 level in each group. Results CPT-11 in the range of 20-200 mol/L can decrease the proliferation rate of EC109 cells. The inhibitory effect was exerted in a dose and time de- pendent manner and the difference was statistically significant (P〈0. 05). Then, the concentration of CPT-11 close to 20% inhibition concentration(IC20) (25 μmol/L) was selected in the following sensitivity test. The SFs of CPT-11+irradiation group were lower than those of the irradiation group, and the Do of CPT-11+group was 1.39±0. 14, lower than 2. 46±0. 17 of irradiation group with SER of 1.77. Compared with the control group and the irradiation group, the apoptotic rate, caspase-3 activation rate and the number of Foci focus were all increased, while the Rad51 level was decreased, and the difference was statistically significant (P〈0. 05). Compared with other two
出处 《临床肿瘤学杂志》 CAS 2016年第11期961-966,共6页 Chinese Clinical Oncology
关键词 食管癌 伊立替康 放疗增敏 核因子-ΚB Esophageal cancer Irinotecan Radiosensitivity Nuclear factor kappa B
  • 相关文献

参考文献10

二级参考文献116

  • 1于静萍,孙志强,倪新初,王坚,李毅,胡莉钧,李栋庆,孙苏平.食管癌患者放疗前后血清血管内皮生长因子变化的临床意义[J].中华放射医学与防护杂志,2011,31(6). 被引量:12
  • 2孙燕,林洪生,朱允中,冯继锋,陈正堂,李攻戍,张湘茹,张宗岐,唐俊舫,史美祺,郝学志,韩慧.长春瑞滨合并顺铂(NP)加参一胶囊或安慰剂治疗晚期非小细胞肺癌的多中心双盲随机临床研究报告[J].中国肺癌杂志,2006,9(3):254-258. 被引量:80
  • 3唐丽萍,徐向英,娄阁,马荣,王晶.开普拓对人宫颈癌荷瘤裸鼠放射增敏作用的实验研究[J].中国现代医学杂志,2006,16(22):3368-3370. 被引量:9
  • 4Gebski V,Burmeister B,Smithers BM,et al.Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma:a meta-analysis[J].Lancet Oncol,2007,8:226. 被引量:1
  • 5Stahl M,Stuschke M,Lehmann N,et al.Chemoradiation w-ith and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus[J].J Clin Oncol,2005,23:2310. 被引量:1
  • 6Cooper JS,Guo MD,Herskovic A,et al.Chemoradiotherapy of locally advanced esophageal cancer[J].J Amer Med Assoc,1999,281:1623. 被引量:1
  • 7Minsky BD,Pajak TF,Ginsberg RJ,et al.INT 0123 (Radiation Therapy Oncology Group 94-05) phase Ⅲ trial of combined-modality therapy for esophageal cancer:high-dose versus standard-dose radiation therapy[J].J Clin Oncol,2002,20:1167. 被引量:1
  • 8Burmeister BH,Smithers BM,Gebski V,et al.Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus:a randomized controlled phase Ⅲ trial[J].Lancet Oncol,2005,6:659. 被引量:1
  • 9Bedenne L,Michel P,Bouche O,et al.Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus:FFCD 9102[J].J Clin Oncol,2007,25:1160. 被引量:1
  • 10Urba SG,Orringer MB,Turrisi A,et al.Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma[J].J Clin Oncol,2001,19:305. 被引量:1

共引文献98

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部